Actively Recruiting
Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Led by Bristol-Myers Squibb · Updated on 2026-04-29
362
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to understand the real-world clinical outcomes and treatment patterns of adults with obstructive hypertrophic cardiomyopathy (HCM) treated with mavacamten, and to understand patient and physician experiences with mavacamten treatment, in the US community-based practice
CONDITIONS
Official Title
Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older at baseline
- Confirmed diagnosis of obstructive hypertrophic cardiomyopathy (HCM)
- Prescribed mavacamten for obstructive HCM at a study site between April 28, 2022, and December 31, 2024
- Never enrolled in any interventional clinical trial involving any cardiac myosin inhibitor (observational studies allowed)
- Not enrolled in any interventional clinical trial at study baseline
- Able to read and understand English and have access to a computer or smartphone to complete the survey (for Phase II patient survey only)
You will not qualify if you...
- None, provided all inclusion criteria are met
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Adelphi Real World
Bollington, Macclesfield, United Kingdom, SK10 5JB
Actively Recruiting
Research Team
B
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here